Orphan Drug Designation We provide full support to obtain orphan drug designation in Japan Lead Consultations with MHLW and interaction until designation is received Robust strategy for ODD including risks and mitigation measures We also support process of obtaining funding from the Japanese government We Are Your Partner for Success in Japan Get in touch